Arrowstreet Capital Limited Partnership Grows Stake in Teleflex Incorporated $TFX

Arrowstreet Capital Limited Partnership lifted its position in Teleflex Incorporated (NYSE:TFX) by 13.5% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 749,992 shares of the medical technology company’s stock after purchasing an additional 89,192 shares during the period. Arrowstreet Capital Limited Partnership’s holdings in Teleflex were worth $91,529,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently modified their holdings of TFX. Empowered Funds LLC lifted its position in Teleflex by 15.8% during the first quarter. Empowered Funds LLC now owns 1,684 shares of the medical technology company’s stock valued at $233,000 after purchasing an additional 230 shares in the last quarter. Jane Street Group LLC raised its holdings in Teleflex by 42.6% during the first quarter. Jane Street Group LLC now owns 6,343 shares of the medical technology company’s stock valued at $877,000 after acquiring an additional 1,895 shares during the period. American Century Companies Inc. raised its holdings in Teleflex by 32.7% during the second quarter. American Century Companies Inc. now owns 13,640 shares of the medical technology company’s stock valued at $1,614,000 after acquiring an additional 3,360 shares during the period. Invesco Ltd. raised its holdings in Teleflex by 1.2% during the second quarter. Invesco Ltd. now owns 135,516 shares of the medical technology company’s stock valued at $16,040,000 after acquiring an additional 1,659 shares during the period. Finally, EverSource Wealth Advisors LLC raised its holdings in Teleflex by 108.1% during the second quarter. EverSource Wealth Advisors LLC now owns 1,003 shares of the medical technology company’s stock valued at $119,000 after acquiring an additional 521 shares during the period. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Teleflex Trading Down 0.5%

Shares of TFX stock opened at $129.83 on Tuesday. Teleflex Incorporated has a 12-month low of $100.18 and a 12-month high of $139.67. The company has a current ratio of 2.55, a quick ratio of 2.03 and a debt-to-equity ratio of 0.82. The stock’s 50-day moving average price is $128.91 and its 200-day moving average price is $119.08. The stock has a market capitalization of $5.75 billion, a price-to-earnings ratio of -5.69, a price-to-earnings-growth ratio of 0.97 and a beta of 0.82.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, May 7th. The medical technology company reported $1.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.21 by $0.18. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.The firm had revenue of $548.30 million for the quarter, compared to analysts’ expectations of $536.91 million. During the same period in the previous year, the firm posted $1.44 earnings per share. The business’s revenue was up 32.3% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Equities research analysts predict that Teleflex Incorporated will post 6.7 EPS for the current fiscal year.

Teleflex Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Monday, May 25th will be issued a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend is Friday, May 22nd. Teleflex’s payout ratio is -5.96%.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on TFX shares. Wells Fargo & Company raised their price target on Teleflex from $130.00 to $138.00 and gave the company an “equal weight” rating in a report on Friday, May 8th. Piper Sandler raised Teleflex from a “neutral” rating to an “overweight” rating and raised their price target for the company from $140.00 to $160.00 in a report on Monday, June 8th. Weiss Ratings reissued a “sell (d)” rating on shares of Teleflex in a report on Friday, March 27th. Royal Bank Of Canada raised Teleflex from a “sector perform” rating to an “outperform” rating and raised their price target for the company from $135.00 to $155.00 in a report on Friday, May 8th. Finally, Mizuho set a $140.00 price target on Teleflex in a report on Friday, May 8th. Four investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Teleflex has a consensus rating of “Hold” and an average target price of $146.00.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.